Alpha Pro Tech, Ltd. (APT) Free cash flow
- Free cash flow · 12 months (USD): Value $5.84M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $5.84M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $6.47M − $625.00K ≈ $5.84M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $6.47M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.55× | Operating cash flow / net income. Period ending 2026-06-30. $6.47M ÷ $4.17M ≈ 1.55× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 6.47M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 625.00K USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 5.84M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | (m) | |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 4.17M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.84M | (m) | $6.47M | $625.00K | (m) | (m) | (m) | $4.17M | (m) | (m) | (m) | 1.55× |
| 2026-03-31 | $5.72M | (m) | $6.34M | $621.00K | (m) | (m) | (m) | $3.59M | (m) | (m) | (m) | 1.77× |
| 2025-12-31 | $1.73M | (m) | $2.37M | $639.00K | (m) | (m) | (m) | $3.53M | (m) | (m) | (m) | 0.67× |
| 2025-09-30 | $2.65M | (m) | $4.46M | $1.81M | (m) | (m) | (m) | $3.68M | (m) | (m) | (m) | 1.21× |
| 2025-06-30 | $2.01M | (m) | $5.87M | $3.86M | (m) | (m) | (m) | $3.57M | (m) | (m) | (m) | 1.65× |
| 2025-03-31 | $-950.00K | (m) | $2.91M | $3.86M | (m) | (m) | (m) | $3.97M | (m) | (m) | (m) | 0.73× |
| 2024-12-31 | $1.89M | (m) | $5.70M | $3.81M | (m) | (m) | (m) | $3.93M | (m) | (m) | (m) | 1.45× |
| 2024-09-30 | $4.15M | (m) | $6.81M | $2.67M | (m) | (m) | (m) | $4.14M | (m) | (m) | (m) | 1.64× |
| 2024-06-30 | $4.81M | (m) | $5.43M | $618.00K | (m) | (m) | (m) | $4.71M | (m) | (m) | (m) | 1.15× |
| 2024-03-31 | $8.40M | (m) | $8.99M | $586.00K | (m) | (m) | (m) | $4.21M | (m) | (m) | (m) | 2.13× |
| 2023-12-31 | $7.67M | (m) | $8.46M | $792.00K | (m) | (m) | (m) | $4.19M | (m) | (m) | (m) | 2.02× |
| 2023-09-30 | $6.25M | (m) | $6.88M | $630.00K | (m) | (m) | (m) | $3.69M | (m) | (m) | (m) | 1.86× |
| 2023-06-30 | $3.66M | (m) | $4.32M | $660.00K | (m) | (m) | (m) | $2.77M | (m) | (m) | (m) | 1.56× |
| 2023-03-31 | $3.11M | (m) | $3.76M | $648.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $3.79M | (m) | $4.28M | $492.00K | (m) | (m) | (m) | $3.28M | (m) | (m) | (m) | 1.30× |
| 2022-09-30 | $948.00K | (m) | $1.43M | $482.00K | (m) | (m) | (m) | $3.32M | (m) | (m) | (m) | 0.43× |
| 2022-06-30 | $2.15M | (m) | $3.43M | $1.28M | (m) | (m) | (m) | $3.58M | (m) | (m) | (m) | 0.96× |
| 2022-03-31 | $-966.00K | (m) | $1.56M | $2.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-3.00M | (m) | $-480.00K | $2.52M | (m) | (m) | (m) | $6.76M | (m) | (m) | (m) | -0.07× |
| 2021-09-30 | $-1.18M | (m) | $1.66M | $2.84M | (m) | (m) | (m) | $13.57M | (m) | (m) | (m) | 0.12× |
| 2021-06-30 | $-3.63M | (m) | $-1.44M | $2.18M | (m) | (m) | (m) | $20.91M | (m) | (m) | (m) | -0.07× |
| 2021-03-31 | $4.74M | (m) | $5.71M | $977.00K | (m) | (m) | (m) | $25.46M | (m) | (m) | (m) | 0.22× |
| 2020-12-31 | $17.14M | (m) | $18.27M | $1.14M | (m) | (m) | (m) | $27.09M | (m) | (m) | (m) | 0.67× |
| 2020-09-30 | $18.22M | (m) | $19.04M | $819.00K | (m) | (m) | (m) | $20.00M | (m) | (m) | (m) | 0.95× |
| 2020-06-30 | $18.20M | (m) | $19.66M | $1.46M | (m) | (m) | (m) | $12.33M | (m) | (m) | (m) | 1.59× |
| 2020-03-31 | $12.44M | (m) | $13.87M | $1.43M | (m) | (m) | (m) | $7.12M | (m) | (m) | (m) | 1.95× |
| 2019-12-31 | $1.80M | (m) | $3.10M | $1.30M | (m) | (m) | (m) | $3.00M | (m) | (m) | (m) | 1.03× |
| 2019-09-30 | $680.00K | (m) | $2.03M | $1.35M | (m) | (m) | (m) | $3.28M | (m) | (m) | (m) | 0.62× |
| 2019-06-30 | $1.44M | (m) | $2.06M | $620.00K | (m) | (m) | (m) | $4.39M | (m) | (m) | (m) | 0.47× |
| 2019-03-31 | $2.41M | (m) | $3.07M | $656.00K | (m) | (m) | (m) | $4.33M | (m) | (m) | (m) | 0.71× |
| 2018-12-31 | $1.39M | (m) | $2.00M | $606.00K | (m) | (m) | (m) | $3.63M | (m) | (m) | (m) | 0.55× |
| 2018-09-30 | $1.68M | (m) | $2.41M | $723.00K | (m) | (m) | (m) | $3.18M | (m) | (m) | (m) | 0.76× |
| 2018-06-30 | $1.74M | (m) | $2.46M | $728.00K | (m) | (m) | (m) | $2.75M | (m) | (m) | (m) | 0.90× |
| 2018-03-31 | $610.00K | (m) | $1.35M | $740.00K | (m) | (m) | (m) | $2.59M | (m) | (m) | (m) | 0.52× |
| 2017-12-31 | $2.79M | (m) | $4.01M | $1.22M | (m) | (m) | (m) | $2.63M | (m) | (m) | (m) | 1.52× |
| 2017-09-30 | $2.51M | (m) | $3.49M | $978.00K | (m) | (m) | (m) | $3.30M | (m) | (m) | (m) | 1.06× |
| 2017-06-30 | $4.81M | (m) | $5.65M | $838.00K | (m) | (m) | (m) | $3.22M | (m) | (m) | (m) | 1.76× |
| 2017-03-31 | $6.86M | (m) | $7.65M | $796.00K | (m) | (m) | (m) | $3.21M | (m) | (m) | (m) | 2.38× |
| 2016-12-31 | $6.57M | (m) | $6.83M | $267.00K | (m) | (m) | (m) | $3.17M | (m) | (m) | (m) | 2.16× |
| 2016-09-30 | $9.63M | (m) | $9.93M | $297.00K | (m) | (m) | (m) | $2.62M | (m) | (m) | (m) | 3.79× |
| 2016-06-30 | $9.71M | (m) | $10.04M | $331.00K | (m) | (m) | (m) | $1.91M | (m) | (m) | (m) | 5.26× |
| 2016-03-31 | $9.06M | (m) | $9.33M | $271.00K | (m) | (m) | (m) | $1.40M | (m) | (m) | (m) | 6.67× |
| 2015-12-31 | $5.70M | (m) | $5.97M | $274.00K | (m) | (m) | (m) | $1.04M | (m) | (m) | (m) | 5.74× |
| 2015-09-30 | $-39.00K | (m) | $205.00K | $244.00K | (m) | (m) | (m) | $1.35M | (m) | (m) | (m) | 0.15× |
| 2015-06-30 | $-1.49M | (m) | $-1.25M | $231.00K | (m) | (m) | (m) | $2.01M | (m) | (m) | (m) | -0.62× |
| 2015-03-31 | $-3.22M | (m) | $-2.23M | $984.00K | (m) | (m) | (m) | $2.62M | (m) | (m) | (m) | -0.85× |
| 2014-12-31 | $-1.83M | (m) | $-879.00K | $947.00K | (m) | (m) | (m) | $2.74M | (m) | (m) | (m) | -0.32× |
| 2014-09-30 | $760.00K | (m) | $1.72M | $957.00K | (m) | (m) | (m) | $2.81M | (m) | (m) | (m) | 0.61× |
| 2014-06-30 | $1.01M | (m) | $2.04M | $1.02M | (m) | (m) | (m) | $2.75M | (m) | (m) | (m) | 0.74× |
| 2014-03-31 | $3.45M | (m) | $3.75M | $299.00K | (m) | (m) | (m) | $2.33M | (m) | (m) | (m) | 1.61× |
| 2013-12-31 | $5.74M | (m) | $6.09M | $349.00K | (m) | (m) | (m) | $2.08M | (m) | (m) | (m) | 2.93× |
| 2013-09-30 | $4.78M | (m) | $5.10M | $322.00K | (m) | (m) | (m) | $1.51M | (m) | (m) | (m) | 3.37× |
| 2013-06-30 | $1.28M | (m) | $1.54M | $255.00K | (m) | (m) | (m) | $1.02M | (m) | (m) | (m) | 1.51× |
| 2013-03-31 | $-92.00K | (m) | $132.00K | $224.00K | (m) | (m) | (m) | $922.00K | (m) | (m) | (m) | 0.14× |
| 2012-12-31 | $-1.53M | (m) | $-1.01M | $519.00K | (m) | (m) | (m) | $977.00K | (m) | (m) | (m) | -1.04× |
| 2012-09-30 | $-275.00K | (m) | $239.00K | $514.00K | (m) | (m) | (m) | $1.21M | (m) | (m) | (m) | 0.20× |
| 2012-06-30 | $2.76M | (m) | $3.33M | $573.00K | (m) | (m) | (m) | $1.19M | (m) | (m) | (m) | 2.81× |
| 2012-03-31 | $4.41M | (m) | $5.00M | $590.00K | (m) | (m) | (m) | $1.11M | (m) | (m) | (m) | 4.49× |
| 2011-12-31 | $3.50M | (m) | $3.77M | $269.00K | (m) | (m) | (m) | $933.00K | (m) | (m) | (m) | 4.04× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-4.58M | (m) | $-3.44M | $1.13M | (m) | (m) | (m) | $1.30M | (m) | (m) | (m) | -2.64× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |